These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1246404

  • 21. Carcinoembryonic antigen in patients with squamous cell carcinoma of the cervix uteri and vulva.
    DiSaia P, Haverback BJ, Dyce BJ, Morrow M.
    Surg Gynecol Obstet; 1974 Apr; 138(4):542-4. PubMed ID: 4205815
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical evaluation of serum CEA levels in uterine cervix cancer].
    Kikuchi Y, Hirose J, Uekita Y, Hayasaka K, Asano A, Nishino S, Mitsuhashi H, Amo K, Washizuka N, Mure I, Yamashita Y.
    Gan No Rinsho; 1983 Apr; 29(4):A-21, 330-5. PubMed ID: 6854968
    [Abstract] [Full Text] [Related]

  • 23. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA, Doering DL, Bosscher JR, Day TG, Rao CV, Owens K, Kelly B, Goldsmith J.
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [Abstract] [Full Text] [Related]

  • 24. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O, Prott FJ, Schäfer U, Tangerding S, Pötter R, Willich N.
    Anticancer Res; 2000 Nov; 20(6D):5113-5. PubMed ID: 11326679
    [Abstract] [Full Text] [Related]

  • 25. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix?
    Patsner B, Orr JW, Allmen T.
    Obstet Gynecol; 1989 Nov; 74(5):786-8. PubMed ID: 2812656
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T.
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [Abstract] [Full Text] [Related]

  • 27. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):249-57. PubMed ID: 15337563
    [Abstract] [Full Text] [Related]

  • 28. Carcinoembryonic antigen in cervical cancer: a five-year follow-up.
    Braun P, Leyendecker G.
    Cancer Detect Prev; 1983 Sep 01; 6(1-2):249-53. PubMed ID: 6883384
    [Abstract] [Full Text] [Related]

  • 29. [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)].
    Ziegenbein R, Jacobasch KH, Pilgrim G, Seifart W.
    Arch Geschwulstforsch; 1980 Sep 01; 50(2):165-8. PubMed ID: 7436700
    [Abstract] [Full Text] [Related]

  • 30. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 01; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 31. [Carcinoembryonic antigen in carcinoma of the uterine cervix. Correlations with clinical stage, histopathology, and survival about 115 cases (author's transl)].
    Bolla M, Vrousos C, Horiot JC, Guerrin J, Bordes M, Le Dorze C.
    Pathol Biol (Paris); 1979 Dec 01; 27(10):611-4. PubMed ID: 395491
    [Abstract] [Full Text] [Related]

  • 32. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Dec 01; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 33. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O, Bruns F, Schäfer U, Prott FJ, Willich N.
    Anticancer Res; 2005 Dec 01; 25(3A):1663-6. PubMed ID: 16033078
    [Abstract] [Full Text] [Related]

  • 34. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
    Meier W, Stieber P, Hasholzner U, Baumgartner L, Fateh-Moghadam A.
    Anticancer Res; 1997 Dec 01; 17(4B):2959-62. PubMed ID: 9329575
    [Abstract] [Full Text] [Related]

  • 35. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
    Waalkes TP, Abeloff MD, Woo KB, Ettinger DS, Ruddon RW, Aldenderfer P.
    Cancer Res; 1980 Dec 01; 40(12):4420-7. PubMed ID: 6254646
    [Abstract] [Full Text] [Related]

  • 36. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM, Crum CP, Pascal RR, Richart RM.
    Diagn Gynecol Obstet; 1981 Dec 01; 3(4):291-9. PubMed ID: 7338157
    [Abstract] [Full Text] [Related]

  • 37. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec 01; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 38. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC, Shiau YC, Chang WC, Kao CH, Lin CC.
    Neoplasma; 2002 Dec 01; 49(6):415-7. PubMed ID: 12584591
    [Abstract] [Full Text] [Related]

  • 39. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F, Yacoub WN, Hagen JA, Mason RJ, Ayazi S, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR.
    J Am Coll Surg; 2008 Jul 01; 207(1):30-5. PubMed ID: 18589358
    [Abstract] [Full Text] [Related]

  • 40. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T.
    Eur J Surg Oncol; 2007 Mar 01; 33(2):183-7. PubMed ID: 17174516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.